STAT6 promotes bi-directional modulation of PKM2 in liver and adipose inflammatory cells in rosiglitazone-treated mice.
STAT6 promotes bi-directional modulation of PKM2 in liver and adipose inflammatory cells in rosiglitazone-treated mice.
复制标题
DOI:
10.1038/srep02350
复制
发表时间:
2013
影响因子:
4.6
通讯作者:
Szanto, Ildiko
中科院分区:
文献类型:
--
作者:
Sajic, Tatjana;Hainard, Alexandre;Scherl, Alexander;Wohlwend, Annelise;Negro, Francesco;Sanchez, Jean-Charles;Szanto, Ildiko
STAT6 interacts with PPARγ to elicit macrophage polarization towards an anti-inflammatory, insulin-sensitizing phenotype. Mice deficient in STAT6 display liver lipid accumulation (hepatosteatosis). Rosiglitazone (RSG), a PPARγ agonist, ameliorates hepatosteatosis and enhances insulin sensitivity. To elucidate the role of STAT6 in PPARγ action on hepatosteatosis we compared liver proteomes of RSG-treated wild type and STAT6-deficient mice and we identified pyruvate kinase M2 (PKM2), a glycolysis and proliferation-regulating enzyme that displayed STAT6-dependent expression. RSG induced PKM2 within inflammatory cells in liver but suppressed its expression in adipose tissue. RSG diminished hepatosteatosis and oxidative stress, enhanced fat accumulation and improved insulin sensitivity in STAT6-deficient mice. Our data reveal a complex interaction between STAT6 and PPARγ in the regulation of liver and adipose tissue lipid depot distribution and design STAT6 as a novel link between inflammatory cell metabolism and adipocyte and hepatocyte function.
登录
查看更多内容
影响因子:
3.3
作者:
Mishra BB;Gundra UM;Teale JM
通讯作者:
Teale JM
影响因子:
4.4
作者:
Iff, Joel;Wang, Wei;Szanto, Ildiko
通讯作者:
Szanto, Ildiko
DOI:
10.1111/j.1742-7843.2010.00553.x
发表时间:
2010-08-01
影响因子:
3.1
作者:
Ackerman, Zvi;Oron-Herman, Mor;Grozovski, Maria
通讯作者:
Grozovski, Maria
影响因子:
20.1
作者:
Chawla A
通讯作者:
Chawla A
影响因子:
9.3
作者:
Foryst-Ludwig A;Hartge M;Clemenz M;Sprang C;Hess K;Marx N;Unger T;Kintscher U
通讯作者:
Kintscher U